Press release
Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic Virus Therapy Development Through Regulatory Approvals
Oncolytic Virus Therapy Market
The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering an immune response against the tumor, creating a two-pronged action plan for efficient cancer management. The American Cancer Society Inc., a non-profit based in the US, projects a grim outlook for 2022, estimating 609,820 cancer-related fatalities and 1,958,310 new cancer diagnoses. Consequently, the escalating rate of cancer incidences is steering the growth of the oncolytic virus therapy market.
Get Your Oncolytic Virus Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/oncolytic-virus-therapy-global-market-report
What is the future CAGR of the oncolytic virus therapy market, and how will it impact industry expansion?
The market for oncolytic virus therapy has witnessed substantial growth in recent years, expanding from $0.19 billion in 2024 to a projected $0.23 billion in 2025, showcasing a compound annual growth rate (CAGR) of 25.4%. This growth during the historic period may be attributed to factors such as improved methods of genetic engineering, enhanced comprehension of the tumor microenvironment, successful clinical trials and regulatory approvals, the increasing prominence of immunotherapy in treating cancer, and advancements in gene delivery systems.
In the upcoming years, the oncolytic virus therapy market is projected to witness remarkable growth, aiming to reach a market value of $0.55 billion by 2029, at a compound annual growth rate (CAGR) of 23.7%. The predicted growth during the forecast period can be credited to the development of oncolytic virus platforms, complementary therapies with immune checkpoint inhibitors, personalized medicine strategies, the broadening of the clinical trial spectrum, and regulatory aid and guidance. Key trends expected during the forecast period range from technological progression in delivery systems, advancements in the field of synthetic biology, cooperation and partnerships within the biopharmaceutical sector, progress in virology and immunology, to emphasis on pediatric oncology.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12391&type=smp
What are the most significant trends transforming the oncolytic virus therapy market today?
Major firms active in the oncolytic virus therapy market are focusing their attention on obtaining authorization from regulatory bodies to quicken the launch of innovative cancer therapies. This approval procedure involves health officials assessing and allowing the use of medical goods which range from drugs and biological products to medical devices. For instance, ImmVira, a biotechnology firm based in China, was granted Fast Track status by the FDA in March 2024 for its MVR-T3011 IT oncolytic virus therapy. This therapy targets recurrent or metastatic head and neck squamous cell carcinoma (HNSCC) in patients who observed disease progression after undergoing platinum-based chemotherapy and at least one preceding anti-PD-1/PD-L1 therapy session. This Fast Track status is designed to speed up the creation and investigation process for treatments aimed at severe conditions that currently lack sufficient medical solutions.
Which key market segments comprise the oncolytic virus therapy market and drive its revenue growth?
The oncolytic virus therapy market covered in this report is segmented -
1) By Therapy Type: HSV-Based Oncolytic Virus Therapy, Adenovirus-Based Oncolytic Virus Therapy, Reovirus, Poxviruses, NDV (Newcastle Disease Virus), Other Therapy Types
2) By Virus Type: Genetically Engineered Oncolytic Viruses, Oncolytic Wild-Type Viruses
3) By Application: Breast Cancer, Lung Cancer, Prostate Cancer, Melanoma, Brain Tumor, Blood Cancer
4) By End-User: Hospitals, Specialty Clinics, Cancer Research Institutes
Subsegments:
1) By HSV-Based Oncolytic Virus Therapy: Talimogene Laherparepvec (T-VEC), Other HSV-Based Therapies
2) By Adenovirus-Based Oncolytic Virus Therapy: Onyx-015, AdV-5/3-D24, Other Adenovirus-Based Therapies
3) By Reovirus: Reolysin, Other Reovirus Therapies
4) By Poxviruses: JX-594 (OncoVac), Other Poxvirus Therapies
5) By NDV (Newcastle Disease Virus): NDV-Based Therapies, Other NDV Applications
6) By Other Therapy Types: Combination Therapies, Other Emerging Oncolytic Virus Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12391
What regions are at the forefront of oncolytic virus therapy market expansion?
North America was the largest region in the oncolytic virus therapy market in 2024 and is expected to be the fastest-growing region in the forecast period. The regions covered in the oncolytic virus therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Who are the leading players fueling growth in the oncolytic virus therapy market?
Major companies operating in the oncolytic virus therapy market include Pfizer Inc., Johnson & Johnson, Sorrento Therapeutics Inc., AbbVie Inc., AstraZeneca plc, Amgen Inc., Boehringer Ingelheim Group, Regeneron Pharmaceuticals, Daiichi Sankyo Company Limited, Kissei Pharmaceutical Co. Ltd., Takara Bio Inc., Oncorus Inc., Replimune Inc., Vyriad Inc., Genelux Corporation, Oncolys BioPharma Inc., Adze Biotechnology, Oncolytics Biotech Inc., TILT Biotherapeutics Ltd., Transgene SA, Circio Holding ASA, Lokon Pharma AB, Provectus Biopharmaceuticals Inc., Vibalogics
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12391&type=smp
What Is Covered In The Oncolytic Virus Therapy Global Market Report?
• Market Size Forecast: Examine the oncolytic virus therapy market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the oncolytic virus therapy market for a structured understanding.
• Key Players Overview: Analyze major players in the oncolytic virus therapy market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the oncolytic virus therapy market.
• Segment Contributions: Evaluate how different segments drive overall growth in the oncolytic virus therapy market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the oncolytic virus therapy market.
• Industry Challenges: Identify potential risks and obstacles affecting the oncolytic virus therapy market.
• Competitive Landscape: Review strategic developments in the oncolytic virus therapy market, including expansions, agreements, and new product launches.
Learn More About The Business Research Company
The Business Research Company provides in-depth research and insights through a vast collection of 15,000+ reports spanning 27 industries and over 60 geographies. Backed by 1,500,000 datasets, extensive secondary research, and expert insights from industry leaders, we equip you with the knowledge needed to stay ahead in the market.
Our flagship offering, the Global Market Model, is a leading market intelligence platform that delivers comprehensive and up-to-date forecasts to support strategic decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic Virus Therapy Development Through Regulatory Approvals here
News-ID: 3902534 • Views: …
More Releases from The Business Research Company
Global Dermal Regeneration Market Expansion at 8.9% CAGR, Valued at $2.52 Billio …
"Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
What Are the Dermal Regeneration Market Size Forecast for 2025?
In recent years, the market size of dermal regeneration has significantly expanded. Its growth is set to continue, moving from a market value of $1.64 billion in 2024, surging to $1.79 billion in 2025, indicating a Compound Annual Growth Rate…
Dental Emergency Kit Market Expansion Outlook: $1.74 Billion in 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Projected CAGR for the Dental Emergency Kit Market from 2024 to 2025?
In recent times, the dental emergency kit market has seen significant growth. Projected growth rates suggest an increase from $1.18 billion in 2024 to $1.28 billion in 2025, manifesting a compound annual growth rate (CAGR) of 8.2%.…
Cryopreservation Equipment Industry Growth Outlook: 15.4% CAGR and $19.55 Billio …
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
What Is the Long-Term Growth Forecast for the Cryopreservation Equipment Market Size 2025?
The expansion of the cryopreservation equipment market has been significant in recent years. The market which is expected to escalate from $9.52 billion in 2024 to $11.01 billion in 2025, will do so with a compound annual growth rate…
Connected Wearable Patches Industry to Achieve $10.78 Billion Growth by 2029
"Get 30% off global market reports with code ONLINE30 and keep ahead of tariffs, macro trends, and worldwide economic developments.
How Will the Connected Wearable Patches Market Grow by 2025 in Terms of Size and Growth?
The market size for connected wearable patches has seen significant expansion in the most recent years. With an expected rise from $5.62 billion in 2024 to $6.42 billion in 2025, representing a compound annual growth rate…
More Releases for Virus
Zika Virus Vaccines Market 2022 | High rate of incidence of active Zika virus in …
Zika Virus Vaccines Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $18,697 million by 2022, registering a CAGR of 5.2% during the forecast period 2017-2022.Key opportunities include the need for vaccines for immunization & prevention of further spread of Zika virus infection and for treatment of Zika-linked birth defects.
Do Enquiry for Sample Report @ https://www.alliedmarketresearch.com/request-sample/1817
The outbreak of Zika virus infection in Latin…
Viral Disease Diagnosis Market - Revolutionary Trends 2025 | Cytomegalovirus, De …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Viral Disease Diagnosis Market to See Huge Growth by 2025 | Measles Virus, Polio …
Global Viral Disease Diagnosis Market: Snapshot
Thousands of deaths are occurring on a yearly basis on account of various viral infectious diseases. Some of the viral diseases occurring are rabies, avian influenza, HIV-1, measles, enterovirus, poliovirus, coronavirus, and Metapneumovirus. This has resulted in global public health concerns. Common influenza, contagious infections, and serious pandemics are some of the issues that need clinical prognosis for an early detection of the infectious agent.…
Virus Free Corporate Training
Interaction for learning is critical but our customers are slowly starting to realise that this doesn’t necessarily need to take place face to face. Virtual instructor led training (VILT) makes learning more accessible by removing geographical barriers. It helps improve user product adoption, knowledge and career development and eliminates the need for costly and time-consuming travel. Still, there’s often a misconception that in person training is the only type of…
Tick-borne Encephalitis Inactivated Vaccine Market Report 2018: Segmentation by …
Global Tick-borne Encephalitis Inactivated Vaccine market research report provides company profile for Pfizer Inc., Encephalitis Global, Inc., The Cochrane Collaboration, Sonic HealthPlus Pty Ltd., Superdrug Health Clinic, GlaxoSmithKline plc, Merck & Co., Inc., Baxter International Inc., London Travel Clinic and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of…
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Prologue to Oncolytic Virus
1.1 Outline of Oncolytic Virotherapy
1.2 Trail from Genesis to Biogenetics
Primer of Virotherapy in Malignancies
2.1 Oncolytic Viruses towards Cancer
2.2 Approaches for Targeting Tumor Cells
2.2.1 Pro Apoptotic Targeting
2.2.2 Translational Targeting
2.2.3 Transcriptional Targeting
2.2.4 Transductional Targeting
Mechanism…
